Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, trades, imports and exports of all kinds of human medicines and health products. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Frequently asked questions
What sector does Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) operate in?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) current stock price?
As of the latest data, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS stock price is TRY 10.87, with a previous close of TRY 11.39. Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS lost -TRY 0.52 in the last trading session, representing a -4.57% loss.
What is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) current market capitalization?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS market cap is approximately 48.81 billion.
What is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) Earnings Per Share (EPS)?
The trailing EPS is TRY 0.14.
What is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) Price-to-Earnings (P/E) ratio?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS current P/E ratio is 77.64.
Does Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) pay dividends?
Yes. Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS pays other dividends with an annualized yield of 0.45% and an estimated annual payout of TRY 0.05 per share.
When is the next ex-dividend date for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL)?
The next ex-dividend date is scheduled for August 04, 2026.
What is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) beta (volatility) score?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS has a beta of -0.052, indicating lower volatility than the overall market.
